Majhail Navneet S
Division of Hematology, Oncology, and Transplantation, University of Minnesota, USA.
Minn Med. 2010 Oct;93(10):45-9.
Hematopoietic stem-cell transplantation is a potentially curative therapy for many high-risk hematologic malignancies and other life-threatening disorders. Advances in transplantation over the last four decades have resulted in an increasing number of long-term survivors who may be at risk for developing late infections, noninfectious complications, and secondary cancers. Awareness on the part of primary care physicians of the risk factors and screening recommendations for late complications can lead to their early diagnosis and treatment.
造血干细胞移植是治疗许多高危血液系统恶性肿瘤和其他危及生命疾病的一种潜在治愈性疗法。在过去四十年中，移植技术的进步使长期存活者的数量不断增加，这些存活者可能面临发生晚期感染、非感染性并发症和继发性癌症的风险。初级保健医生若能了解晚期并发症的危险因素和筛查建议，有助于实现这些并发症的早期诊断和治疗。
